How should an elderly patient on chronic warfarin who sustained a ground‑level fall without obvious head injury be managed?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 11, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Management of Elderly Patients on Warfarin After Ground-Level Fall Without Obvious Head Injury

All elderly patients on warfarin who sustain a ground-level fall require immediate non-contrast head CT regardless of the absence of obvious head injury or symptoms, as warfarin increases the risk of intracranial hemorrhage by 40% and doubles mortality risk even after seemingly minor trauma. 1

Immediate Diagnostic Evaluation

Mandatory Imaging

  • Obtain immediate non-contrast head CT in all anticoagulated patients with head trauma, regardless of mechanism severity, presence of symptoms, or Glasgow Coma Scale score. 1, 2
  • Warfarin-anticoagulated patients have a 10.2% risk of intracranial hemorrhage after head trauma compared to 2.6% with NOACs and 1.5% in non-anticoagulated patients. 1
  • The American College of Emergency Physicians provides Level B recommendation that all patients on anticoagulants require head CT after any head trauma. 1

Laboratory Assessment

  • Check INR, PT, aPTT, and fibrinogen levels immediately upon presentation. 3
  • The degree of coagulopathy (INR level) correlates with bleeding risk and guides reversal strategy. 4

Management Based on Initial CT Results

If CT Shows Intracranial Hemorrhage

Immediately discontinue warfarin and initiate urgent reversal with 4-factor prothrombin complex concentrate (4F-PCC) plus 5mg intravenous vitamin K to achieve INR <1.5. 4, 3

Reversal Protocol

  • Administer 4F-PCC as first-line agent (strong recommendation over FFP). 4
  • Give 5mg intravenous vitamin K concurrently. 4, 3
  • PCC achieves INR reversal below 1.5 in 81% of patients within 8 hours, compared to only 29% with FFP. 5
  • Recheck INR after reversal agents are administered to confirm adequate reversal (target INR <1.5). 3
  • Use FFP only if PCC is unavailable (strong recommendation based on moderate quality evidence). 4
  • Do NOT use recombinant factor VIIa as first-line reversal agent. 4

Additional Hemorrhage Management

  • Consider tranexamic acid 1g IV over 10 minutes if treatment can be given within 3 hours of injury onset (reduces head injury-related death with risk ratio 0.78). 3, 1
  • Obtain immediate neurosurgical consultation for all confirmed intracranial hemorrhages. 3, 1
  • Obtain repeat head CT within 24 hours, as anticoagulated patients have 3-fold increased risk of hemorrhage expansion (26% versus 9% in non-anticoagulated patients). 3, 1, 2

If Initial CT is Negative

Neurologically intact patients (GCS 15, no loss of consciousness, no post-traumatic amnesia) with negative initial CT can be safely discharged without repeat imaging or observation. 1, 2

Discharge Criteria

  • Patient must be at baseline neurologic examination. 1
  • Glasgow Coma Scale score must be 15. 1
  • No loss of consciousness or post-traumatic amnesia. 1
  • Risk of delayed intracranial hemorrhage requiring intervention after negative initial CT is extremely low (<1%). 1, 2

Anticoagulation Management After Negative CT

  • Do NOT routinely discontinue warfarin after negative initial CT in neurologically intact patients, as thromboembolic risk may outweigh the small risk of delayed hemorrhage. 1, 2
  • The indication for anticoagulation (atrial fibrillation, mechanical valve, prior thromboembolism) must be weighed against fall risk. 6

Discharge Instructions

  • Provide written discharge instructions including warning signs requiring immediate return (severe headache, vomiting, confusion, weakness, seizure). 1, 2
  • Arrange for responsible adult observation at home. 1
  • Schedule outpatient follow-up for fall risk assessment and reassessment of anticoagulation risk/benefit ratio. 3, 1

Special Considerations for High-Risk Elderly

Consider Brief Observation (4-6 Hours) If:

  • Age >80 years with loss of consciousness or amnesia. 1
  • Any alteration in mental status even if transient. 2
  • Multiple falls or high fall risk. 1

Monitoring During Observation

  • Document half-hourly neurologic checks until stable. 3
  • Any neurological deterioration requires immediate repeat CT imaging. 3, 2

Common Pitfalls to Avoid

  • Do NOT delay head CT based on absence of symptoms or minor mechanism—warfarin increases ICH risk even with ground-level falls. 1, 7
  • Do NOT use FFP as first-line reversal when PCC is available—PCC is faster, requires smaller volume, and achieves better INR correction. 4, 5
  • Do NOT delay reversal while waiting for laboratory confirmation if clinical suspicion for hemorrhage is high. 3
  • Do NOT unnecessarily discontinue warfarin after negative CT without considering thromboembolic risk—the risk of stroke or thromboembolism may exceed the minimal risk of delayed hemorrhage. 1, 2
  • Do NOT perform routine repeat imaging in stable patients with negative initial CT—this increases costs and radiation exposure without benefit. 1, 2

Prognostic Information

  • Mortality in anticoagulated elderly with traumatic intracranial hemorrhage ranges from 50-91% depending on initial GCS and INR level. 7, 8
  • Patients with initial GCS 13-15 can deteriorate rapidly within hours despite normal initial CT, emphasizing need for close monitoring if admitted. 8
  • Warfarin use is associated with 75% unfavorable outcomes (death or severe disability) in elderly with fall-induced traumatic intracranial hemorrhage, compared to 27% in non-anticoagulated patients. 9

References

Guideline

Evaluation of Head Injury in Anticoagulated Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Imaging Guidelines for Patients on Apixaban Anticoagulation with Head Trauma

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Management of Intracranial Hemorrhage in Patients on Anticoagulants

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Traumatic brain injury in anticoagulated patients.

The Journal of trauma, 2006

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.